CD2 and the nature of protein interactions mediating cell-cell recognition

Immunological Reviews

Volumn 163, Issue , 1998, Pages 217-236

  Davis, Simon J ^a   Ikemizu, Shinji ^b   Wild, Martin K ^c   Van Der Merwe, P Anton ^c  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN;

ANTIGEN RECOGNITION; CELL INTERACTION; LIGAND BINDING; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD2; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION;

EID: 0031817313     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1998.tb01199.x     Document Type: Review

References (102)

1. Williams AF, Galfre G, Milstein C. Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: differentiation antigens of rat lymphocytes. Cell 1977;12:663-673.
2. Barclay AN, Brown MH, Law SKA, McKnight AJ, Tomlinson MG, van der Merwe PA. The leukocyte antigen facts book. 2nd ed. London: Academic Press; 1997.
3. Selvaraj P, Plunkett ML, Dustin M, Sanders ME, Shaw S, Springer TA. The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3. Nature 1987;326:400-403.
4. Sayre PH, Hussey RE, Chang HC, Ciardelli TL, Reinherz EL. Structural and binding analysis of a two domain extracellular CD2 molecule. J Exp Med 1989;169:995-1009.
5. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987;329:506-512.
6. Wang JH, et al. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature 1990;348:411-418.
7. Ryu SE, et al. Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature 1990;348:419-426.
8. Davis SJ, van der Merwe PA. The structure and ligand interactions of CD2: implications for T-cell function. Immunol Today 1996;17:177-187.
9. Springer TA, Dustin ML, Kishimoto TK, Marlin SD. The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. Annu Rev Immunol 1987;5:223-252.
10. Bierer BE, Sleckman BP, Ratnofsky SE, Burakoff SJ. The biologic roles of CD2, CD4, and CD8 in T-cell activation. Annu Rev Immunol 1989;7:579-599.
11. Moingeon P, et al. The structural biology of CD2. Immunol Rev 1989;111:111-144.
12. Hunig T. The cell surface molecule recognized by the erythrocyte receptor of T lymphocytes. Identification and partial characterization using a monoclonal antibody. J Exp Med 1985;162:890-901.
13. Sewell WA, Brown MH, Dunne J, Owen MJ, Crumpton MJ. Molecular cloning of the human T-lymphocyte surface CD2 (T11) antigen. Proc Natl Acad Sci USA 1986;83:8718-8722.
14. Sayre PH, et al. Molecular cloning and expression of T11 cDNAs reveal a receptor-like structure on human T lymphocytes. Proc Natl Acad Sci USA 1987;84:2941-2945.
15. Seed B, Aruffo A. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc Natl Acad Sci USA 1987;84:3365-3369.
16. Seed B. An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2. Nature 1987;329:840-842.
17. Wallner BP, et al. Primary structure of lymphocyte function-associated antigen 3 (LFA-3). The ligand of the T lymphocyte CD2 glycoprotein. J Exp Med 1987;166:923-932.
18. Killeen N, Moessner R, Arvieux J, Willis A, Williams AF. The MRC OX-45 antigen of rat leukocytes and endothelium is in a subset of the immunoglobulin superfamily with CD2, LFA-3 and carcinoembryonic antigens. EMBO J 1988;7:3087-3091.
19. Sewell WA, et al. The human LFA-3 gene is located at the same chromosome band as the gene for its receptor CD2. Immunogenetics 1988;28:278-282.
20. Kingsmore SF, Watson ML, Moseley WS, Seldin MF. Physical linkage of genes encoding the lymphocyte adhesion molecules CD2 and its ligand LFA-3. Immunogenetics 1989;30:123-125.
21. Wong YW, Williams AF, Kingsmore SF, Seldin MF. Structure, expression, and genetic linkage of the mouse BCM1 (OX45 or Blast-1) antigen. Evidence for genetic duplication giving rise to the BCM1 region on mouse chromosome 1 and the CD2/LFA3 region on mouse chromosome 3. J Exp Med 1990;171:2115-2130.
22. Kato K, et al. CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation. J Exp Med 1992;176:1241-1249.
23. 2-terminal domain of rat CD2 binds rat CD48 with a low affinity and binding does not require glycosylation of CD2. Eur J Immunol 1993;23:1373-1377.
24. Arulanandam AR, et al. A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice. J Exp Med 1993;177:1439-1450.
25. Hahn WC, Menu E, Bothwell AL, Sims PJ, Bierer BE. Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59. Science 1992;256:1805-1807.
26. Van der Merwe PA, et al. Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59. Biochemistry 1994;33:10149-10160.
27. Killeen N, Stuart SG, Littman DR. Development and function of T cells in mice with a disrupted CD2 gene. EMBO J 1992;11:4329-4336.
28. Matsui K, Boniface JJ, Reay PA, Schild H, Fazekas de St. Groth B, Davis MM. Low affinity interaction of peptide-MHC complexes with T cell receptors. Science 1991;254:1788-1791.
29. Davis SJ, Jones EY, Bodian DL, Barclay AN, van der Merwe PA. Analysis of the structure and interactions of CD2. Biochem Soc Trans 1993;21:952-958.
30. Van der Merwe PA, Barclay AN. Transient intercellular adhesion: the importance of weak protein-protein interactions. Trends Biochem Sci 1994;19:354-358.
31. Van der Merwe PA, Brown MH, Davis SJ, Barclay AN. Affinity and kinetic analysis of the interaction of the cell-adhesion molecules rat CD2 and CD48. EMBO J 1993;12:4945-4954.
32. Van der Merwe PA, Bodian DL, Daenke S, Linsley P, Davis SJ. CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J Exp Med 1997;185:393-403.
33. Nicholson MW, Barclay AN, Singer MS, Rosen SD, van der Merwe PA. Affinity and kinetic analysis of L-selectin (CD62L) binding to GlyCAM-1. J Biol Chem 1998;273:763-770.
34. Pierres A, Benoliel AM, Bongrand P, van der Merwe PA. Determination of the life-time and force dependence of interactions of single bonds between surface-attached CD2 and CD48 adhesion molecules. Proc Natl Acad Sci USA 1994;93: 15114-15118.
35. Pierres A, Benoliel AM, Bongrand P, van der Merwe PA. The dependence of the association rate of surface-attached adhesion molecules CD2 and CD48 on separation distance. FEBS Lett 1997;403:239-244.
36. Evans CF, Rall GF, Killeen N, Littman D, Oldstone MBA. CD2-deficient mice generate virus-specific cytotoxic T lymphocytes upon infection with lymphocytic choriomeningitis. J Immunol 1993;151:6259-6264.
37. Teh SJ, Killeen N, Tarakhovsky A, Littman DR, Teh HS. CD2 regulates positive selection and function of antigen-specific CD4-CD8+ T cells. Blood 1997;89:1308-1318.
38. McAlister MS, Mott HR, van der Merwe PA, Campbell ID, Davis SJ, Driscoll PC. NMR analysis of interacting soluble forms of the cell-cell recognition molecules CD2 and CD48. Biochemistry 1996;35:5982-5991.
39. Dustin ML, Ferguson LM, Chan PY, Springer TA, Golan DE. Visualization of CD2 interaction with LFA-3 and determination of the two-dimensional dissociation constant for adhesion receptors in a contact area. J Cell Biol 1996;132:465-474.
40. Dustin ML, et al. Low affinity interaction of human or rat cell adhesion molecule CD2 with ligands aligns adhering membranes to achieve high physiological affinity. J Biol Chem 1997;272:30889-30898.
41. Dustin ML. Adhesive bond dynamics in contacts between T lymphocytes and glass-supported planar bilayers reconstituted with the immunoglobulin-related adhesion molecule CD58. J Biol Chem 1997;272:15782-15788.
42. Williams AF, Barclay AN. Glycoprotein antigens of the lymphocyte surface and their purification by antibody affinity chromatography. In: Weir DM, Herzenberg LA, Blackwell C, Herzenberg LA, eds. Handbook of experimental immunology. London: Blackwell Scientific Publications; 1986.p.22.1-22.24.
43. Bell GI, Dembo M, Bongrand P. Cell adhesion: competition between non-specific repulsion and specific bonding. Biophys J 1984;45:1051-1064.
44. Van der Merwe PA, McNamee PN, Davies EA, Barclay AN, Davis SJ. Topology of the CD2-CD48 cell-adhesion molecule complex: implications for antigen recognition by T cells. Curr Biol 1995;5:74-84.
45. Bell GI. Models for the specific adhesion of cells to cells. Science 1978;200:618-627.
46. Evans E, Berk D, Leung A. Detachment of agglutinin-bonded red blood cells. I. Forces to rupture molecular-point attachments. Biophys J 1991;59:838-848.
47. Leckband D, Müller W, Schmitt FJ, Ringsdorf H. Molecular mechanisms determining the strength of receptor-mediated intermembrane adhesion. Biophys J 1995;69:1162-1169.
48. Valitutti S, Lanzavecchia A. Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition. Immunol Today 1997;18:299-304.
49. Lanier LL, Phillips JH. Inhibitory MHC class I receptors on NK cells and T cells. Immunol Today 1996;17:86-91.
50. Thompson CB, Allison JP. The emerging role of CTLA-4 as an immune attenuator. Immunity 1997;7:445-450.
51. Alam SM, et al. T-cell-receptor affinity and thymocyte positive selection. Nature 1996;381:616-620.
52. Lyons DS, et al. A TCR binds antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity 1996;5:53-61.
53. Cyster JG. Leukosialin and CD2: contrasting structures at the cell surface [DPhil thesis]. Oxford: Oxford Univ; 1992.
54. Driscoll PC, Cyster JG, Campbell ID, Williams AF. Structure of domain 1 of rat T lymphocyte CD2 antigen. Nature 1991;353:762-765.
55. Williams AF, Barclay AN, Clark SJ, Paterson DJ, Willis AC. Similarities in sequences and cellular expression between rat CD2 and CD4 antigens. J Exp Med 1987;165:368-380.
56. Withka JM, Wyss DF, Wagner G, Arulanandam AR, Reinherz EL, Recny MA. Structure of the glycosylated adhesion domain of human T lymphocyte glycoprotein CD2. Structure 1993;1:69-81.
57. Stanley P. Chinese hamster ovary cell mutants with multiple glycosylation defects for production of glycoproteins with minimal carbohydrate heterogeneity. Mol Cell Biol 1989;9:377-383.
58. Davis SJ, et al. Expression of soluble recombinant glycoproteins with predefined glycosylation: application to the crystallization of the T-cell glycoprotein CD2. Protein Eng 1993;6:229-232.
59. Davis SJ, et al. Ligand binding by the immunoglobulin superfamily recognition molecule CD2 is glycosylation-independent. J Biol Chem 1995;270:369-375.
60. Jones EY, Davis SJ, Williams AF, Harlos K, Stuart DI. Crystal structure at 2.8 Å resolution of a soluble form of the cell adhesion molecule CD2. Nature 1992;360:232-239.
61. Bodian DL, Jones EY, Harlos K, Stuart DI, Davis SJ. Crystal structure of the extracellular region of the human cell adhesion molecule CD2 at 2.5 Å resolution. Structure 1994;2:755-766.
62. Tavernor AS, et al. Expression cloning of an equine T-lymphocyte glycoprotein CD2 cDNA. Structure-based analysis of conserved sequence elements. Eur J Biochem 1994;219:969-976.
63. Davis SJ, van der Merwe PA. CD2: an exception to the immunoglobulin superfamily concept? Science 1996;273:1241-1242.
64. Recny MA, et al. N-glycosylation is required for human CD2 immunoadhesion functions. J Biol Chem 1992;267:22428-22434.
65. Wyss DF, et al. Conformation and function of the N-linked glycan in the adhesion domain of human CD2. Science 1995;269:1273-1278.
66. Imperiali B, Rickert KW. Conformational implications of asparagine-linked glycosylation. Proc Natl Acad Sci USA 1995;92:97-101.
67. Helenius A, Trombetta ES, Hebert DN, Simons JF. Calnexin, calreticulin and the folding of glycoproteins. Trends Cell Biol 1997;7:193-199.
68. Davis SJ, Davies EA, Tucknott MG, Jones EY, van der Merwe PA. The role of charged residues mediating low affinity protein-protein recognition at the cell surface by CD2. Proc Natl Acad Sci USA 1998;95:5490-5494.
69. Somoza C, Driscoll PC, Cyster JG, Williams AF. Mutational analysis of the CD2/CD58 interaction: the binding site for CD58 lies on one face of the first domain of human CD2. J Exp Med 1993;178:549-558.
70. Arulanandam AR, et al. The CD58 (LFA-3) binding site is a localized and highly charged surface area on the AGFCC′C″ face of the human CD2 adhesion domain. Proc Natl Acad Sci USA 1993;90: 11613-11617.
71. Janin J, Chothia C. The structure of protein-protein recognition sites. J Biol Chem 1990;265:16027-16030.
72. Miller S, Janin J, Lesk AM, Chothia C. Interior and surface of monomeric proteins. J Mol Biol 1987;196:641-656.
73. Creighton TE. Proteins: structures and molecular properties. 2nd ed. New York: WH Freeman and Co; 1993.
74. Chothia C, Janin J. Principles of protein-protein recognition. Nature 1975;256:705-708.
75. Ikemizu S, et al. Crystal structure of the CD2-binding immunoglobulin superfamily domain of LFA-3(CD58) at 1.8Å resolution. (In preparation).
76. Arulanandam AR, Kister A, McGregor MJ, Wyss DF, Wagner G, Reinherz EL. Interaction between human CD2 and CD58 involves the major beta sheet surface of each of their respective adhesion domains. J Exp Med 1994;180:1861-1871.
77. Osborn L, et al. Amino acid residues required for binding of lymphocyte function-associated antigen 3 (CD58) to its counter-receptor CD2. J Exp Med 1995;181:429-434.
78. Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 1996;384:134-141.
79. Garcia KC, et al. Structural basis of plasticity in the T cell receptor recognition of a self peptide-MHC antigen. Science 1998;279:1166-1172.
80. Van der Merwe PA, Brown MH, Davis SJ, Barclay AN. Measuring very low affinity interactions between immunoglobulin superfamily cell-adhesion molecules. Biochem Soc Trans 1993;21:340S.
81. Shapiro L, Doyle JP, Hensley P, Colman DR, Hendrickson WA. Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron 1996;17:435-449.
82. Jones EY, et al. Crystal structure of an integrin-binding fragment of vascular cell adhesion molecule-1 at 1.8 Å resolution. Nature 1995;373:539-544.
83. Karlsson R, Michaelsson A, Mattsson L. Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system. J Immunol Methods 1991;145:229-240.
84. Kraulis PJ. Molscript: a program to produce both detailed and schematic plots of protein structures. J Appl Crystallography 1991;24:946-950.
85. Sayle RA, Milner-White EJ. RASMOL: biomolecular graphics for all. Trends Biochem Sci 1995;20:374-376.
86. Cocks BG, Chang CC, Carballido JM, Yssel H, de Vries JE, Aversa G. A novel receptor involved in T-cell activation. Nature 1995;376:260-263.
87. Mathew PA, et al. Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. J Immunol 1993;151:5328-5337.
88. Sandrin MS, et al. Isolation and characterization of cDNA clones for mouse Ly-9. J Immunol 1992;149:1636-1641.
89. Nicholls A, Sharp K, Honig B. Protein folding and association; insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 1991;11:281-296.
90. Van der Merwe PA, Crocker P, Vincent M, Barclay AN, Kelm S. Localization of the putative sialic acid binding site on the immunoglobulin superfamily cell surface molecule CD22. J Biol Chem 1996;271:9273-9280.
91. Vinson M, van der Merwe PA, Kelm S, May A, Jones EY, Crocker PR. Characterization of the sialic acid-binding site in sialoadhesin by site-directed mutagenesis. J Biol Chem 1996;271:9267-9272.
92. Peterson A, Seed B. Monoclonal antibody and ligand binding sites of the T cell erythrocyte receptor (CD2). Nature 1987;329:842-846.
93. Peach RJ, et al. Both extracellular immunoglobulin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28. J Biol Chem 1995;270:21181-21187.
94. Metzler WJ, et al. Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28. Nat Struct Biol 1997;4:527-531.
95. Aruffo A, et al. CD6-ligand interactions: a paradigm for SRCR domain function? Immunol Today 1997;18:498-504.
96. Silkowski H, Davis SJ, Barclay AN, Rowe AJ, Harding SE, Byron O. Characterization of the low affinity interaction between rat cell adhesion molecules CD2 and CD48 by analytical ultracentrifugation. Eur Biophys J 1997;25:455-462.
97. Matsui K, Boniface JJ, Steffner P, Reay PA, Davis MM. Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness. Proc Natl Acad Sci USA 1994;91: 12862-12866.
98. Garcia KC, et al. CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature 1996;384:577-581.
99. Weber S, Karjalainen K. Mouse CD4 binds MHC class II with extremely low affinity. Int Immunol 1993;5:695-698.
100. Fan QR, Garbozi DN, Winter CC, Wagtmann N, Long EO, Wiley DC. Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule. Proc Natl Acad Sci USA 1996;93:7178-7183.
101. Lollo BA, Chan KWH, Hanson EM, Moy VT, Brian AA. Direct evidence for two affinity states for lymphocyte function-associated antigen 1 on activated cells. J Biol Chem 1993;268:21693-21700.
102. Powell LD, Jain RK, Matta KL, Sabesan S, Varki A. Characterization of sialyloligosaccharide binding by recombinant soluble and native cell-associated CD22 - evidence for a minimal structural recognition motif and the potential importance of multisite binding. J Biol Chem 1995;270:7523-7532.